Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor… - Journal of Allergy and …, 2009 - Elsevier
BACKGROUND: Many children with asthma continue to experience symptoms despite
available therapies. OBJECTIVE: This study evaluated the efficacy and safety of …
available therapies. OBJECTIVE: This study evaluated the efficacy and safety of …
[HTML][HTML] Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma
A Papi, GW Canonica, P Maestrelli… - … England Journal of …, 2007 - Mass Medical Soc
Background Treatment guidelines recommend the regular use of inhaled corticosteroids for
patients with mild persistent asthma. We investigated whether the symptom-driven use of a …
patients with mild persistent asthma. We investigated whether the symptom-driven use of a …
[图书][B] Medical Pharmacology and Therapeutics E-Book: Medical Pharmacology and Therapeutics E-Book
DG Waller, AW Hitchings - 2021 - books.google.com
Medical Pharmacology & Therapeutics provides all the information medical and healthcare
students need throughout their degree programme and beyond, including for professional …
students need throughout their degree programme and beyond, including for professional …
[HTML][HTML] Importance of inhaler devices in the management of airway disease
JC Virchow, GK Crompton, R Dal Negro, S Pedersen… - Respiratory …, 2008 - Elsevier
The delivery of drugs by inhalation is an integral component of asthma and chronic
obstructive pulmonary disease (COPD) management. However, even with effective inhaled …
obstructive pulmonary disease (COPD) management. However, even with effective inhaled …
Serious asthma events with fluticasone plus salmeterol versus fluticasone alone
DA Stempel, IH Raphiou, KM Kral… - … England Journal of …, 2016 - Mass Medical Soc
Background The safe and appropriate use of long-acting beta-agonists (LABAs) for the
treatment of asthma has been widely debated. In two large clinical trials, investigators found …
treatment of asthma has been widely debated. In two large clinical trials, investigators found …
Identification of a β-arrestin-biased negative allosteric modulator for the β2-adrenergic receptor
M Ippolito, F De Pascali, N Hopfinger… - Proceedings of the …, 2023 - National Acad Sciences
Catecholamine-stimulated β2-adrenergic receptor (β2AR) signaling via the canonical Gs–
adenylyl cyclase–cAMP–PKA pathway regulates numerous physiological functions …
adenylyl cyclase–cAMP–PKA pathway regulates numerous physiological functions …
Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine
VE Ortega, DA Meyers - Journal of allergy and clinical immunology, 2014 - Elsevier
Pharmacogenetics is being used to develop personalized therapies specific to subjects from
different ethnic or racial groups. To date, pharmacogenetic studies have been primarily …
different ethnic or racial groups. To date, pharmacogenetic studies have been primarily …
Physiological and biological responses to short-term intermittent hypobaric hypoxia exposure: from sports and mountain medicine to new biomedical applications
G Viscor, JR Torrella, L Corral, A Ricart… - Frontiers in …, 2018 - frontiersin.org
In recent years, the altitude acclimatization responses elicited by short-term intermittent
exposure to hypoxia have been subject to renewed attention. The main goal of short-term …
exposure to hypoxia have been subject to renewed attention. The main goal of short-term …
Addition of long‐acting beta2‐agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma
FM Ducharme, MN Chroinin… - Cochrane Database …, 2010 - cochranelibrary.com
Background In asthmatic patients inadequately controlled on inhaled corticosteroids and/or
those with moderate persistent asthma, two main options are recommended: the …
those with moderate persistent asthma, two main options are recommended: the …
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
JA Van Noord, JL Aumann, E Janssens, J Verhaert… - Chest, 2006 - Elsevier
Background The combination of short-acting β 2-agonists and anticholinergics in the
treatment of COPD has been well documented, but data on combination of long-acting …
treatment of COPD has been well documented, but data on combination of long-acting …